Stroke is a leading cause of permanent disability. Therefore, primary prevention of first
stroke and secondary prevention of recurrent stroke are a high priority. Primary prevention of …

Concepts and our approaches to stroke prevention in atrial fibrillation (AF) have changed
markedly over the last decade. There has been an evolution over the approach to stroke and …

Background The effect of early as compared with later initiation of direct oral anticoagulants
(DOACs) in persons with atrial fibrillation who have had an acute ischemic stroke is unclear …

Background The risk of stroke is heterogeneous across different groups of patients with atrial
fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide …

Stroke is a major contributor to death and disability worldwide. Prior to modern therapy, post-
stroke mortality was approximately 10% in the acute period, with nearly one-half of the …

Atrial fibrillation (AF) is an increasingly prevalent arrhythmia; its pathophysiology and
progression are well studied. Stroke and bleeding risk models have been created and …

Background The optimal timing to administer non–vitamin K oral anticoagulants (NOAC s) in
patients with acute ischemic stroke and atrial fibrillation is unclear. This prospective …

Rationale Atrial fibrillation causes one-fifth of ischemic strokes, with a high risk of early
recurrence. Although long-term anticoagulation is highly effective for stroke prevention in …

Purpose of review Decision-making on resuming oral anticoagulant (OAC) after
intracerebral hemorrhage (ICH) evokes significant debate among clinicians. Such patients …

Because of demographic aging, the prevalence of arterial hypertension (HTN) and cardiac
arrhythmias, namely atrial fibrillation (AF), is progressively increasing. Not only are these …